Atlas Trials

Single-dose Potassium Supplementation in Patients With ADHD for Whom the Anesthetic Lidocaine is Ineffective

Clinical trial NCT03563573 · UNKNOWN

Trial details

NCT number
NCT03563573
Sponsor
AlkaliDx, Inc.
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
ADHD
Start date
2018-07-01
Primary completion
2018-11-04
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.